(2010). Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice.
(2009). An epidemic of postsurgical infections caused by Mycobacterium massiliense.
(2007). CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
(2009). Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.
(2002). Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.
(2011). Diversity of pulsedfield gel electrophoresis patterns of Mycobacterium abscessus type 2 clinical isolates.
(1995). Drugresistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice.
(2010). Epidemic of surgical-site infections by a single clone of rapidly growing mycobacteria in Brazil.
(2001). Fordham von Reyn C
(2009). Foxp3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis.
(1997). Glutaraldehyde-resistant Mycobacterium chelonae from endoscope washer disinfectors.
(1997). Has BCG attenuated to impotence?
(2010). Host immune response to rapidly-growing mycobacteria, an emerging cause of chronic lung disease.
(2007). Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.
(2010). Increasing reports of non-tuberculous mycobacteria in England,
(2008). Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.
La Scola B et al (2004) Amoebal coculture of ‘‘Mycobacterium massiliense’’ from the sputum of a patient with hemoptoic pneumonia.
(2008). Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection.
(2006). Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
(2001). Nontuberculous mycobacteria.
(2010). Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.
(1998). Nosocomial outbreaks/pseudooutbreaks caused by nontuberculous mycobacteria.
(2007). Outbreak of Mycobacterium massiliense infection associated with intramuscular injections.
(2010). Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis.
(1999). Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection.
(2008). Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates.
(2000). Rapid neutrophil response controls fast-replicating intracellular bacteria but not slowreplicating Mycobacterium tuberculosis.
(2009). Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.
(2006). Relationships between mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils.
(2006). rpoB gene sequencebased characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii, Mycobacterium phocaicum and Mycobacterium aubagnense.
Shamputa IC et al (2009) Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense,a n dMycobacterium bolletii.JC l i nM i c r o b i o
(2008). Spectrum of CNS disease caused by rapidly growing mycobacteria.
(2009). T cells in mycobacterial infection and disease.
(2007). The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.
(1999). The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity.
(2008). The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence.
(2009). The role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
(2008). The theoretical influence of immunity between strain groups on the progression of drug resistant tuberculosis epidemics.
(2003). Tolllike receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.
(2010). Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis i n f e c t i o nw i t hn o r m a lg r a n u l o m as t r u c t u r ei na cynomolgus macaque model.
(1995). Variation in protection by BCG: implications of and for heterologous immunity.